Clinical Trial Update: Phase 1/2a, Randomized, Double-Blind, Placebo-Controlled, Study to Assess Safety, Tolerability, PK and PD Response of PB1023 Injection Following Single and Multiple SQ Doses in Adults With Type 2 Diabetes Mellitus [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes the Phase 1/2a randomized, double-blind, placebo-controlled study of PB1023 in adults with Type 2 diabetes to assess safety…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PB1023

Snippet

Sponsor: PhaseBio Pharmaceuticals Inc. | Conditions: Diabetes Mellitus, Type 2 | Phase 1, Phase 2 | Status: COMPLETED